USA - NYSE:AGL - US00857U1079 - Common Stock
The current stock price of AGL is 0.9135 USD. In the past month the price decreased by -11.31%. In the past year, price decreased by -66.17%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 12.97 | 104.26B | ||
| CI | THE CIGNA GROUP | 10.98 | 82.32B | ||
| LH | LABCORP HOLDINGS INC | 17.15 | 21.58B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 207.87 | 20.25B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.27 | 19.94B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.34 | 15.90B | ||
| HIMS | HIMS & HERS HEALTH INC | 58.9 | 10.65B | ||
| DVA | DAVITA INC | 13.38 | 9.27B | ||
| GH | GUARDANT HEALTH INC | N/A | 8.68B | ||
| CHE | CHEMED CORP | 19.62 | 6.40B | ||
| RDNT | RADNET INC | 219.72 | 6.08B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 61.82 | 6.02B |
Agilon Health, Inc. engages in providing healthcare services. The company is headquartered in Westerville, Ohio and currently employs 1,076 full-time employees. The company went IPO on 2021-04-15. The company enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). The company focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.
AGILON HEALTH INC
440 Polaris Parkway, Suite 550
Westerville OHIO US
CEO: Steve Sell
Employees: 1076
Phone: 15622563800
Agilon Health, Inc. engages in providing healthcare services. The company is headquartered in Westerville, Ohio and currently employs 1,076 full-time employees. The company went IPO on 2021-04-15. The company enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). The company focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.
The current stock price of AGL is 0.9135 USD. The price decreased by -3.47% in the last trading session.
AGL does not pay a dividend.
AGL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
AGL stock is listed on the New York Stock Exchange, Inc. exchange.
AGILON HEALTH INC (AGL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.77).
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AGL.
ChartMill assigns a fundamental rating of 3 / 10 to AGL. While AGL seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months AGL reported a non-GAAP Earnings per Share(EPS) of -0.77. The EPS decreased by -35.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -18.43% | ||
| ROE | -77.19% | ||
| Debt/Equity | 0 |
26 analysts have analysed AGL and the average price target is 1.99 USD. This implies a price increase of 117.31% is expected in the next year compared to the current price of 0.9135.
For the next year, analysts expect an EPS growth of 2.28% and a revenue growth -3.96% for AGL